4//SEC Filing
Pasternak Andy 4
Accession 0001209191-23-000879
CIK 0001492426other
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:14 PM ET
Size
24.3 KB
Accession
0001209191-23-000879
Insider Transaction Report
Form 4
Pasternak Andy
EVP and Chief Business Officer
Transactions
- Tax Payment
Ordinary Shares
2022-12-30$113.80/sh−39,313$4,473,819→ 83,467 total - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−8,709→ 0 total→ Ordinary Shares (8,709 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−5,800→ 0 total→ Ordinary Shares (5,800 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−11,648→ 5,816 total→ Ordinary Shares (11,648 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−14,514→ 0 total→ Ordinary Shares (14,514 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−11,643→ 11,643 total→ Ordinary Shares (11,643 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−26,124→ 0 total→ Ordinary Shares (26,124 underlying) - Exercise/Conversion
Performance Restricted Stock Units (PSU)
2022-12-30−2,360→ 0 total→ Ordinary Shares (2,360 underlying) - Exercise/Conversion
Restricted Stock Units (RSU)
2022-12-30−7,935→ 15,870 total→ Ordinary Shares (7,935 underlying) - Exercise/Conversion
Ordinary Shares
2022-12-30+88,733→ 122,780 total
Footnotes (4)
- [F1]Each PSU/RSU represents a contingent right to receive one ordinary share of the Issuer.
- [F2]The final tranche of ordinary shares subject to the PSU/RSU vested on December 30, 2022.
- [F3]The remaining ordinary shares subject to the PSU/RSU vest on January 5, 2024.
- [F4]The remaining ordinary shares subject to the RSU vest ratably on January 5, 2024 and January 5, 2025.
Documents
Issuer
Horizon Therapeutics Public Ltd Co
CIK 0001492426
Entity typeother
Related Parties
1- filerCIK 0001792746
Filing Metadata
- Form type
- 4
- Filed
- Jan 3, 7:00 PM ET
- Accepted
- Jan 4, 4:14 PM ET
- Size
- 24.3 KB